2018
DOI: 10.1016/j.bmcl.2017.12.033
|View full text |Cite
|
Sign up to set email alerts
|

Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…Cytarabine, sorafenib and vorinostat presented higher sensitivity in high-risk group, which may lead to new treatment options for patients with early-stage CRC. In particular, bexarotene, bicalutamide and imatinib were also reported to suppress EMT and metastasis [25][26][27][28][29].…”
Section: Correlation Between the Tumor Immune Microenvironment And Th...mentioning
confidence: 99%
“…Cytarabine, sorafenib and vorinostat presented higher sensitivity in high-risk group, which may lead to new treatment options for patients with early-stage CRC. In particular, bexarotene, bicalutamide and imatinib were also reported to suppress EMT and metastasis [25][26][27][28][29].…”
Section: Correlation Between the Tumor Immune Microenvironment And Th...mentioning
confidence: 99%
“…Alkamides have also been investigated as treatments for cancer. For example, alkamide derivatives of bexarotene were able to induce apoptosis and prevent cell migration and proliferation in triple-negative breast cancer cells, while showing no cytotoxic effects against normal mammary epithelial cells [69]. In addition, a panel of alkamides with varying structure and molecular weights were able to induce differentiation of human leukemia cells to granulocyte-like cells [70].…”
Section: Cancer Cellsmentioning
confidence: 99%
“…In addition, it inhibited NOTCH signaling pathway which is related to cell invasion and migration [146]. Furthermore, several apocarotenoids inhibited migration and EMT associated factors in BT-549 and MDA-MB-231 [147]. Therefore, carotenoids and apocarotenoids could be helpful preventing metastasis in triple negative tumors.…”
Section: In Vitro and In Vivo Studiesmentioning
confidence: 99%